{
    "clinical_study": {
        "@rank": "65353", 
        "arm_group": [
            {
                "arm_group_label": "control group", 
                "description": "a control group of AR patients who visited the ear nose and throat (ENT) department of the University Hospitals Leuven in the same time period"
            }, 
            {
                "arm_group_label": "patients having SCIT", 
                "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010."
            }
        ], 
        "brief_summary": {
            "textblock": "Allergic rhinitis (AR) is defined as inflammation of the nasal mucosa after exposition to an\n      allergen in sensitized patients. AR causes not only nasal symptoms such as sneezing, itchy\n      nose, rhinorrhea and nasal obstruction, but also has a significant impact on quality of\n      life. Symptom control and overall satisfaction in patients undergoing subcutaneous\n      immunotherapy (SCIT) or sublingual immunotherapy (SLIT) on the long term has not yet been\n      investigated so far."
        }, 
        "brief_title": "Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "a control group of AR patients who visited the ENT department of the University Hospitals Leuven in the same time period", 
                            "title": "Control Group"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010.", 
                            "title": "Patients Having SCIT"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "352"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "82"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "434"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "352"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "82"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "434"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "201"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "48"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "249"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "151"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "34"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "185"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "352"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "82"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "434"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Belgium"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Percentage patients in both groups that still use medication for their allergic rhinitis symptoms, 3 years after starting their therapy (non IT-group vs IT-group)", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "a control group of AR patients who visited the ENT department of the University Hospitals Leuven in the same time period", 
                                    "title": "Control Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010.", 
                                    "title": "Patients Having SCIT"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "352"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "82"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "61"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "29"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Percentage patients in both groups that still use medication for their allergic rhinitis symptoms, 3 years after starting their therapy (non IT-group vs IT-group)", 
                                    "param": "Number", 
                                    "title": "Current Medication Use Three Years After Diagnosis of AR", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "3 years after starting SCIT", 
                        "title": "Current Medication Use Three Years After Diagnosis of AR", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Based on the proposed cut-off value of VAS < 5/10 for total nasal symptoms (TNS), rhinitis was considered as being controlled in 69 IT patients (84%) versus 223 (63%) non-IT patients", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "a control group of AR patients who visited the ENT department of the University Hospitals Leuven in the same time period", 
                                    "title": "Control Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010.", 
                                    "title": "Patients Having SCIT"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "352"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "82"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "63"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "84"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Based on the proposed cut-off value of VAS < 5/10 for total nasal symptoms (TNS), rhinitis was considered as being controlled in 69 IT patients (84%) versus 223 (63%) non-IT patients", 
                                    "param": "Number", 
                                    "title": "Percentage of Patients Having Controlled Allergic Rhinosinusitis (AR) Symptoms 3 Years After Starting Treatment", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "3 years after starting SCIT", 
                        "title": "Percentage of Patients Having Controlled Allergic Rhinosinusitis (AR) Symptoms 3 Years After Starting Treatment", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Visual analogue scale (VAS) scores for TNS experienced during the last 4 weeks. Visual analog scales (VAS) have been used to rate the presence of symptoms or impairment of the daily activities. Patients had to answer each question by indicating a position with a vertical line between two endpoints, 0 cm for not bothersome versus 10 cm for extremely bothersome. In this way each question is scored between 0 and 10 points.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "a control group of AR patients who visited the ENT department of the University Hospitals Leuven in the same time period", 
                                    "title": "Control Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010.", 
                                    "title": "Patients Having SCIT"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "353"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "81"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.8", 
                                                        "@value": "3.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.3", 
                                                        "@value": "2.5"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Visual analogue scale (VAS) scores for TNS experienced during the last 4 weeks. Visual analog scales (VAS) have been used to rate the presence of symptoms or impairment of the daily activities. Patients had to answer each question by indicating a position with a vertical line between two endpoints, 0 cm for not bothersome versus 10 cm for extremely bothersome. In this way each question is scored between 0 and 10 points.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Degree of Symptom Control 3 Years After IT or 3 Years After Medical Treatment With VAS of Total Nasal Symptom < 5/10 Defined as a Controlled Situation.", 
                                    "units": "Score on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "3 years after diagnosis", 
                        "title": "Degree of Symptom Control 3 Years After IT or 3 Years After Medical Treatment With VAS of Total Nasal Symptom < 5/10 Defined as a Controlled Situation.", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "ARIA classification of AR is made by duration and severity of AR symptoms. Here are calculated the number of patients having mild acute rhinitis.\nClinical practice guidelines such as the Allergic Rhinitis and its Impact on Asthma (ARIA) document focus on the quality of life as a principal consideration in assessment and treatment of AR", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "a control group of AR patients who visited the ENT department of the University Hospitals Leuven in the same time period", 
                                    "title": "Control Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010.", 
                                    "title": "Patients Having SCIT"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "353"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "81"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "32"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "78"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "ARIA classification of AR is made by duration and severity of AR symptoms. Here are calculated the number of patients having mild acute rhinitis.\nClinical practice guidelines such as the Allergic Rhinitis and its Impact on Asthma (ARIA) document focus on the quality of life as a principal consideration in assessment and treatment of AR", 
                                    "param": "Number", 
                                    "title": "Percentage of Patients That Met ARIA Criteria for Mild AR Symtoms at a Mean Interval of 3 Years After Diagnosis", 
                                    "units": "percentage of  participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "3 years after diagnosis", 
                        "title": "Percentage of Patients That Met ARIA Criteria for Mild AR Symtoms at a Mean Interval of 3 Years After Diagnosis", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "a control group of AR patients who visited the ENT department of the University Hospitals Leuven in the same time period", 
                            "title": "Control Group"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "patients who started immunotherapy at the Department of Allergology of the University Hospitals Leuven between November 2007 and February 2010.", 
                            "title": "Patients Having SCIT"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "352", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "82", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "352", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "82", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "peter.hellings@uzleuven.be", 
                "name_or_title": "Dr Hellings", 
                "organization": "UZ Leuven", 
                "phone": "+32 16 332338"
            }
        }, 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": "Rhinitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients with at least 2 AR symptoms and a positive skin prick test for the 20 most\n             prevalent inhalant allergens (house dust mites, grass pollen, tree pollen, animal\n             dander, Alternaria, Penicillium and Cladosporium) in Belgium.\n\n          2. Moderate/severe and/or persistent AR according to ARIA guidelines\n\n          3. Age > 18 and < 60 years.\n\n          4. Written informed consent\n\n          5. Dutch, French or English speaking patients\n\n        Exclusion Criteria:\n\n        Exclusion criteria\n\n          1. Age < 18 and > 60 years\n\n          2. Patients with mild AR\n\n          3. Patients not being able to give an informed consent\n\n          4. Patients being enrolled in other clinical trials\n\n          5. No knowledge of Dutch, French or English"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "59 Years", 
            "minimum_age": "19 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients who started immunotherapy"
            }
        }, 
        "enrollment": {
            "#text": "434", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 23, 2013", 
        "firstreceived_results_date": "August 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01777438", 
            "org_study_id": "102012"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 24, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "state": "Vlaams-Brabant", 
                        "zip": "3000"
                    }, 
                    "name": "ORL"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "state": "Vlaams-brabant", 
                        "zip": "3000"
                    }, 
                    "name": "UZ Leuven"
                }
            }
        ], 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "2", 
        "official_title": "Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy", 
        "overall_official": {
            "affiliation": "UZ Leuven", 
            "last_name": "Peter Hellings, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Percentage patients in both groups that still use medication for their allergic rhinitis symptoms, 3 years after starting their therapy (non IT-group vs IT-group)", 
                "measure": "Current Medication Use Three Years After Diagnosis of AR", 
                "safety_issue": "No", 
                "time_frame": "3 years after starting SCIT"
            }, 
            {
                "description": "Visual analogue scale (VAS) scores for TNS experienced during the last 4 weeks. Visual analog scales (VAS) have been used to rate the presence of symptoms or impairment of the daily activities. Patients had to answer each question by indicating a position with a vertical line between two endpoints, 0 cm for not bothersome versus 10 cm for extremely bothersome. In this way each question is scored between 0 and 10 points.", 
                "measure": "Degree of Symptom Control 3 Years After IT or 3 Years After Medical Treatment With VAS of Total Nasal Symptom < 5/10 Defined as a Controlled Situation.", 
                "safety_issue": "No", 
                "time_frame": "3 years after diagnosis"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01777438"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Based on the proposed cut-off value of VAS < 5/10 for total nasal symptoms (TNS), rhinitis was considered as being controlled in 69 IT patients (84%) versus 223 (63%) non-IT patients", 
                "measure": "Percentage of Patients Having Controlled Allergic Rhinosinusitis (AR) Symptoms 3 Years After Starting Treatment", 
                "safety_issue": "No", 
                "time_frame": "3 years after starting SCIT"
            }, 
            {
                "description": "ARIA classification of AR is made by duration and severity of AR symptoms. Here are calculated the number of patients having mild acute rhinitis.\nClinical practice guidelines such as the Allergic Rhinitis and its Impact on Asthma (ARIA) document focus on the quality of life as a principal consideration in assessment and treatment of AR", 
                "measure": "Percentage of Patients That Met ARIA Criteria for Mild AR Symtoms at a Mean Interval of 3 Years After Diagnosis", 
                "safety_issue": "No", 
                "time_frame": "3 years after diagnosis"
            }
        ], 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}